The code block below illustrates how one might use # and // as comments in your logic and calculations.

This value you provided is not a number. Please try again.

This value you provided is not an integer. Please try again.

The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again.

The value you provided must be within the suggested range

The value you provided is outside the suggested range

This value is admissible, but you may wish to double check it.

The value entered must be a time value in the following format HH:MM within the range 00:00-23:59 (e.g., 04:32 or 23:19).

This field must be a 5 or 9 digit U.S. ZIP Code (like 94043). Please re-enter it now.

This field must be a 10 digit U.S. phone number (like 415 555 1212). Please re-enter it now.

This field must be a valid email address (like joe@user.com). Please re-enter it now.

The value you provided could not be validated because it does not follow the expected format. Please try again.

Required format:

BjU9DZobQeUuLQqkBbpgqcJ7GcRGoqiL3pIy6piuPe4eV3NVW8fEg4njyCC

KUCC Membership Application

We look forward to having you join The University of Kansas Cancer Center.

To apply for membership, please complete the form below.

First Name

* must provide value

Last Name

* must provide value

Middle Initial

Email Address

* must provide value

Phone

* must provide value

Institution

* must provide value

KU Medical Center - Kansas City

KU Medical Center - Wichita

KU Medical Center - Salina

KU Lawrence

Children's Mercy

Stowers Institute for Medical Research

Other

reset

Other Institution

* must provide value

Department

* must provide value

Department Administrative Contact Name

* must provide value

Department Administrative Contact Email

* must provide value

Academic Title(s)

* must provide value

Academic Degree(s)

* must provide value

MyNCBI bibliography link

ORCiD

Your Institutional Website or Lab Website

Please provide a brief description of your cancer research interests.

* must provide value

Expand

Please provide a few keywords that describe your cancer research interests.

* must provide value

Expand

Please list your active collaborations with other University of Kansas Cancer Center members.

Expand

Please upload a current Biosketch or CV

Upload file

Cancer Biology

The development of new therapies, especially in the era of targeted treatments and personalized medicine, is driven by understanding the underlying cell biology, molecular biology and biochemistry of tumor cells and their surrounding microenvironments. The Cancer Biology research program represents basic science initiatives of The University of Kansas Cancer Center. Members focus on four discipline-based themes: 1) cancer metastasis and tumor microenvironment; 2) DNA damage/repair and regulation; 3) stem cell biology; and 4) cell signaling pathways.

Members of the Cancer Biology research program aim to understand the molecular mechanisms that define normal and neoplastic cell growth to identify and characterize cells, molecules, pathways and processes that are involved in cancer growth and progression. Their findings can serve as useful biomarkers or new cellular targets for cancer prevention and therapeutics. Members focus their efforts on the cancers that most affect people in the cancer center’s catchment area. Overall, their goal is to advance promising basic discoveries into clinical trials.

The Cancer Biology research program is led by Tomoo Iwakuma , MD, PhD, Linheng Li, PhD, Kristi Neufeld, PhD, and Sufi Thomas, PhD.

Cancer Prevention and Control

About 42% of cancer cases and 45% of cancer deaths in the U.S. are believed to be preventable. The Cancer Prevention and Control research program at The University of Kansas Cancer Center brings together researchers focused on identifying new ways to prevent cancer and improve cancer outcomes, with a focus on high-risk and underserved communities in the cancer center’s catchment area. This includes: 1) developing, testing and implementing innovative strategies to modify behaviors that drive cancer risk and cancer incidence disparities; 2) identifying biomarker-driven and other testing strategies that detect cancer earlier and/or reduce cancer risk ; and 3) developing and disseminating behavioral, nutritional and clinical support interventions to address the impact of cancer.

Cancer Prevention and Control members represent a rich mix of expertise, including behavioral science, neuroscience, primary care, nursing, oncology, epidemiology, economics, translational biology, pharmacology, communications, biostatistics, and health services research. Their work has led to a better understanding of the cancer control needs in the cancer center’s catchment area; improved capacity to analyze the needs of affected and at-risk populations; identification of novel precancerous models and new biomarkers; improved strategies to detect and prevent cancer in high-risk patients; better strategies for the design and delivery of cancer prevention and control messages; and improved delivery of tobacco control, cancer screening, physical activity, obesity and survivorship programs at the level of both the clinical practice and the community-at-large.

The Cancer Prevention and Control research program is led by Edward Ellerbeck, MD, MPH, Jennifer Klemp, PhD, MPH, and Nikki Nollen, PhD.

Drug Discovery, Delivery and Experimental Therapeutics

It takes a community of researchers, physicians, patients and support staff to discover and develop new ways to prevent, detect and treat cancer. The Drug Discovery, Delivery and Experimental Therapeutics research program at The University of Kansas Cancer Center integrates a broad range of research areas that contribute to the discovery of new cancer therapeutic agents as well as novel approaches to effective drug delivery; the development of drug products and diagnostics for the treatment and prevention of cancer; and the evaluation of these medical innovations in hypothesis-driven experimental therapeutics trials.

The Drug Discovery, Delivery and Experimental Therapeutics research program is organized around three themes: 1) drug discovery and delivery; 2) drug and diagnostic development; and 3) evaluation of new cancer treatment strategies in clinical trials. The program forms and drives project teams, led by principal investigators and project managers, comprised of basic, translational, and clinical scientists representing multiple disciplines. To bring promising new cancer treatments and diagnostics to patients, members of the Drug Discovery, Delivery and Experimental Therapeutics research program collaborate with industry, academia, government and disease philanthropy partners.

The Drug Discovery, Delivery and Experimental Therapeutics research program is led by Dan Dixon, PhD, Priyanka Sharma, MD, and John Taylor, MD, MS.

Please indicate the Cancer Center program in which you think your research fits:

* must provide value

Cancer Biology

Cancer Prevention & Control

Drug Discovery, Delivery and Experimental Therapeutics

Not Sure

reset

You have selected an option that triggers this survey to end right now.

To save your responses and end the survey, click the 'End Survey' button below. If you have selected the wrong option by accident and/or wish to return to the survey, click the 'Return and Edit Response' button.